These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30005625)

  • 1. Anthropometric and blood parameters for the prediction of NAFLD among overweight and obese adults.
    Kühn T; Nonnenmacher T; Sookthai D; Schübel R; Quintana Pacheco DA; von Stackelberg O; Graf ME; Johnson T; Schlett CL; Kirsten R; Ulrich CM; Kaaks R; Kauczor HU; Nattenmüller J
    BMC Gastroenterol; 2018 Jul; 18(1):113. PubMed ID: 30005625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ability of insulin resistance and lipid-related indices to predict the presence of NAFLD in obese adolescents.
    Yetim A; Şahin M; Kandemir İ; Bulakçı B; Aksakal MT; Karapınar E; Sever H; Baş F
    Lipids Health Dis; 2024 Jul; 23(1):208. PubMed ID: 38956572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.
    Abeysekera KWM; Orr JG; Gordon FH; Howe LD; Hamilton-Shield J; Heron J; Hickman M
    BMC Gastroenterol; 2022 Jun; 22(1):323. PubMed ID: 35773644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin-leptin ratio for the early detection of lean non-alcoholic fatty liver disease independent of insulin resistance.
    Lu CW; Yang KC; Chi YC; Wu TY; Chiang CH; Chang HH; Huang KC; Yang WS
    Ann Med; 2023 Dec; 55(1):634-642. PubMed ID: 36790383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults.
    Cantero I; Elorz M; Abete I; Marin BA; Herrero JI; Monreal JI; Benito A; Quiroga J; Martínez A; Huarte MP; Uriz-Otano JI; Tur JA; Kearney J; Martinez JA; Zulet MA
    Int J Med Sci; 2019; 16(1):75-83. PubMed ID: 30662331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy.
    Martin-Rodriguez JL; Gonzalez-Cantero J; Gonzalez-Cantero A; Arrebola JP; Gonzalez-Calvin JL
    Medicine (Baltimore); 2017 Apr; 96(17):e6770. PubMed ID: 28445310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease.
    Shao C; Ye J; Li F; Feng S; Wang W; Zhong B
    Dig Liver Dis; 2019 Oct; 51(10):1392-1399. PubMed ID: 30928418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
    Maruszczak K; Radzikowski K; Schütz S; Mangge H; Bergsten P; Forslund A; Manell H; Pixner T; Ahlström H; Kullberg J; Mörwald K; Weghuber D
    Front Endocrinol (Lausanne); 2022; 13():1004128. PubMed ID: 36133310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
    El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
    Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children.
    Koot BG; van der Baan-Slootweg OH; Bohte AE; Nederveen AJ; van Werven JR; Tamminga-Smeulders CL; Merkus MP; Schaap FG; Jansen PL; Stoker J; Benninga MA
    Obesity (Silver Spring); 2013 Mar; 21(3):583-90. PubMed ID: 23592667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents.
    Jain V; Jana M; Upadhyay B; Ahmad N; Jain O; Upadhyay AD; Ramakrishnan L; Vikram NK
    Indian J Med Res; 2018 Sep; 148(3):291-301. PubMed ID: 30425219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
    Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.
    Thiagarajan S; Shrinuvasan S; Arun Babu T
    Indian J Gastroenterol; 2022 Feb; 41(1):63-68. PubMed ID: 35064452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study.
    Yang S; Zhong J; Ye M; Miao L; Lu G; Xu C; Xue Z; Zhou X
    Lipids Health Dis; 2020 Nov; 19(1):242. PubMed ID: 33222696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity.
    Chen J; Yue J; Fu J; He S; Liu Q; Yang M; Zhang W; Xu H; Lu Q; Ma J
    Endocr J; 2023 Oct; 70(10):977-985. PubMed ID: 37599066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
    Mohamed RZ; Jalaludin MY; Anuar Zaini A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters.
    Chunming L; Jianhui S; Hongguang Z; Chunwu Q; Xiaoyun H; Lijun Y; Xuejun Y
    Turk J Gastroenterol; 2015 Sep; 26(5):408-16. PubMed ID: 26215061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
    Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
    World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.